Pelthos Therapeutics Inc (PTHS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 7,406 | 0 | 0 | 0 | 0 |
| Cost of Goods | 2,316 | N/A | N/A | N/A | N/A |
| Gross Profit | 5,090 | N/A | N/A | N/A | N/A |
| Operating Expenses | 20,768 | 3,230 | 1,834 | 1,824 | 2,049 |
| Operating Income | -15,362 | -3,230 | -1,834 | -1,824 | -2,049 |
| Interest Expense | 1,346 | 219 | 134 | 108 | 39 |
| Other Income | 5 | 0 | 0 | 6 | 393 |
| Pre-tax Income | -16,703 | -3,449 | -1,968 | -1,926 | -1,695 |
| Income Tax | -465 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -16,238 | -3,449 | -1,968 | -1,926 | -1,695 |
| Net Income | $-16,238 | $-3,449 | $-1,968 | $-1,926 | $-1,695 |
| EPS Basic Total Ops | -5.30 | -5.38 | -3.20 | -2.80 | -2.93 |
| EPS Basic Continuous Ops | -5.30 | -5.38 | -3.21 | -2.82 | -2.93 |
| EPS Diluted Total Ops | -5.30 | -5.38 | -3.20 | -2.80 | -2.93 |
| EPS Diluted Continuous Ops | -5.30 | -5.38 | -3.21 | -2.82 | -2.93 |
| EPS Diluted Before Non-Recurring Items | -5.30 | -5.38 | -3.20 | -3.20 | -2.90 |
| EBITDA(a) | $-14,220 | $-3,066 | $-1,740 | $-1,748 | $-2,039 |